SR

Satheesh B. Ravula

EB Epigen Biosciences: 6 patents #1 of 6Top 20%
CP Curtana Pharmaceuticals: 2 patents #6 of 8Top 75%
University of California: 2 patents #4,561 of 18,278Top 25%
UR University Of Rochester: 2 patents #256 of 1,162Top 25%
📍 San Diego, CA: #3,629 of 23,606 inventorsTop 20%
🗺 California: #50,852 of 386,348 inventorsTop 15%
Overall (All Time): #394,271 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
12357570 Chemoembolization agents James Na, David Imagawa, Fabio Tucci, Graham Beaton 2025-07-15
12234224 Pyrimidine and pyridine amine compounds and usage thereof in disease treatment Graham Beaton, Fabio Tucci, Suk Joong Lee, Chandravadan R. Shah 2025-02-25
11866421 Pyrimidine and pyridine amine compounds and usage thereof in disease treatment Graham Beaton, Fabio Tucci, Suk Joong Lee, Chandravadan R. Shah 2024-01-09
11712418 Chemoembolization agents James Na, David Imagawa, Fabio Tucci, Graham Beaton 2023-08-01
11691951 Inhibition of Olig2 activity Graham Beaton, Fabio Tucci, Stanton McHardy, Francisco Xavier RUIZ, Ambrosio Lopez, Jr. +2 more 2023-07-04
11427552 Heterocyclic compounds useful in the treatment of disease Graham Beaton, Fabio Tucci, Chandravadan R. Shah, Hiep Luu 2022-08-30
10570103 Heterocyclic compounds useful in the treatment of disease Graham Beaton, Fabio Tucci, Chandravadan R. Shah, Hiep Luu 2020-02-25
10526298 Heterocyclic compounds useful in the treatment of disease Graham Beaton, Fabio Tucci, Chandravadan R. Shah, Hiep Luu 2020-01-07
10227333 Inhibition of OLIG2 activity Graham Beaton, Fabio Tucci, Hua Wang 2019-03-12
10000459 Heterocyclic compounds useful in the treatment of disease Graham Beaton, Fabio Tucci, Chandravadan R. Shah, Hiep Luu 2018-06-19
9370515 Mixed lineage kinase inhibitors and method of treatments Val S. Goodfellow, Thong X. Nguyen, Harris A. Gelbard 2016-06-21
8846909 Bicyclic heteroaryl kinase inhibitors and methods of use Harris A. Gelbard, Stephen Dewhurst, Val S. Goodfellow, Torsten Wiemann, Colin J. Loweth 2014-09-30